|
Additional narrative: reporter is a j&j employee.A product investigation was conducted.The complaint device was evaluated and investigated by the pd engineering team.The product was returned to depuy synthes and sent to raynham pd for evaluation.The raynham pd team conducted a visual inspection of the returned device.Visual analysis of the returned sample was performed on mmg tablet.The tablet had no signs of physical damage.A functional test was performed on mmg tablet.Upon powering up the device and entering a procedure with a shorted probe and sensor, the tablet displayed a system fault and no audible alarm sounded.The tablet was not able to establish communication with a known good control unit.Admin mode was accessed.Procedure folders were copied over to kingston r&d drive then to network complaint folder for the investigation archival.The dimensional inspection was not performed since it was not applicable to the complaint condition.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.The overall complaint was confirmed for the mmg tablet.There is no indication that a design or manufacturing issue has caused the complaint condition and hence the root cause cannot be determined.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.A review of the receiving inspection (ri) for mmg tablet was conducted identifying that lot number 3000226 was released in one batch.Batch1: lot qty of (b)(4) units were released on 06 aug 2019 with no discrepancies.As a result, the ri identified no issues during the manufacturing and release of this device that could have contributed to the problem reported by the customer device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|